|
| |
Articles
1-171 out of 171 article(s)
| Title |
Author |
Type |
Date |
Words |
| Otsuka Launches First Skin Patch Treatment for Parkinson's Disease and Restless Legs Syndrome. |
|
|
Feb 24, 2013 |
388 |
| Researchers at Scripps to Study Possible New Treatment for Parkinson's Disease. |
|
|
Jan 25, 2013 |
1067 |
| Foundation Venture Capital Group Invests In Start-Up Working to Reduce Side Effects of Parkinson's Treatment. |
|
|
Jan 25, 2013 |
675 |
| Amarantus BioScience Announces Positive Efficacy Data for MANF in a Nigral Delivery Neurorestoration Animal Model of Parkinson's Disease. |
|
|
Jan 9, 2013 |
1389 |
| 'Parkinson's Drug Market Will Reach $3426 Million in 2016' Predicts New Visiongain Report. |
|
|
Jan 8, 2013 |
1207 |
| Oncodesign And the Laboratory for Neurobiology and Gene Therapy at The KU Leuven Enter into a Research Collaboration for Advancing Drug Discovery Efforts with Ipsen in Parkinson's Disease. |
|
|
Dec 18, 2012 |
1480 |
| Promising drug slows down progression of Parkinson's disease. |
|
|
Dec 1, 2012 |
425 |
| PARKINSON'S PILL MADE ME A GAMBLING & GAY SEX ADDICT; Drug firm pays [euro]200,000 damages. |
|
|
Nov 30, 2012 |
255 |
| PARKINSON'S PILL MADE ME GAMBLER AND GAY SEX ADDICT; Drug firm pays PS160,000 damages. |
|
|
Nov 30, 2012 |
267 |
| PARKINSON'S PILL MADE ME A GAMBLING & GAY SEX ADDICT; Drug firm pays PS160,000 damages. |
|
|
Nov 30, 2012 |
258 |
| PARKINSON'S PILL MADE ME A GAMBLING & GAY SEX ADDICT; Drug firm pays PS160,000 damages. |
|
|
Nov 30, 2012 |
278 |
| Man wins [pounds sterling]160k damages after Parkinson's drug turned him into 'gay sex and gambling addict'. |
|
|
Nov 30, 2012 |
245 |
| Married Man Didier Jambart Became Gay Gambling Sex Addict After Taking GSK Parkinson's Drug. |
|
|
Nov 29, 2012 |
618 |
| NeuroDerm Announces Enrollment in a Phase 1 Study of ND0612, a Continuous Levodopa/Carbidopa Drug for the Treatment of Parkinson's Disease. |
|
|
Nov 20, 2012 |
639 |
| Research and Markets: Key Findings from Treatment Algorithms: Parkinson's Disease. |
|
|
Oct 10, 2012 |
420 |
| New Hopes for Effective Treatment of Parkinson's by Using Carbon Nanotubes. |
|
Disease/Disorder overview |
Aug 29, 2012 |
288 |
| InSightec Receives FDA Approval to Begin Phase I Parkinson's Trial. |
|
|
Aug 20, 2012 |
440 |
| Parkinson's drugs can turn you into a sex addict. |
|
|
Jul 31, 2012 |
350 |
| Parkinson's drug decreases impulsive tendency in adults. |
|
|
Jul 26, 2012 |
517 |
| New drug blocks development of Parkinson's in animal model. |
|
|
Jul 24, 2012 |
468 |
| New Hopes for Effective Treatment of Parkinson's by Using Carbon Nanotubes. |
|
Disease/Disorder overview |
Jul 14, 2012 |
288 |
| Drug for Parkinson's comes closer to reality. |
|
|
Jun 28, 2012 |
518 |
| Finding Brings Scientists One Step Closer To Parkinson's Drug. |
|
|
Jun 27, 2012 |
580 |
| 'Brain pacemaker' effective against Parkinson's for 3 years. |
|
|
Jun 24, 2012 |
483 |
| Single drug could help treat range of brain diseases. |
|
|
May 7, 2012 |
632 |
| Neupro[R] Approved by U.S. FDA for Parkinson's Disease and Restless Legs Syndrome. |
|
|
Apr 3, 2012 |
3076 |
| REPEAT/ Neupro[R] Approved by U.S. FDA for Parkinson's Disease and Restless Legs Syndrome. |
|
|
Apr 3, 2012 |
3076 |
| Turmeric compound shows promise for Parkinson's treatment. |
|
|
Mar 21, 2012 |
352 |
| RBCC Moves Forward on Term Sheet with Parkinson's Drug Therapy Target. |
|
|
Mar 8, 2012 |
440 |
| FDA Accepts Impax Pharmaceuticals NDA Filing for IPX066 for the Treatment of Idiopathic Parkinson's Disease. |
|
|
Feb 23, 2012 |
847 |
| Research and Markets: Global Parkinson's Disease Drug Pipeline Capsule - 2012. |
|
|
Feb 15, 2012 |
450 |
| Impax Pharmaceuticals Submits New Drug Application for IPX066 in Parkinson's Disease. |
|
|
Dec 21, 2011 |
1034 |
| Ceregene Completes Enrollment of Second Phase 2 Study of CERE-120 for the Treatment of Parkinson's Disease. |
|
|
Dec 1, 2011 |
1217 |
| US man claims Parkinson's medication turned him into sex addict. |
|
|
Nov 17, 2011 |
197 |
| Nasogastric medication for perioperative Parkinson's rigidity during anaesthesia emergence. |
Stagg, P.; Grice, T. |
Case study |
Nov 1, 2011 |
1884 |
| The Majority of Parkinson's Disease Patients Maintain Their Use of Key Therapies Throughout Drug Regimen Adjustments. |
|
|
Oct 20, 2011 |
692 |
| Through 2020, Growth in the Parkinson's Disease Drug Market Will Be Constrained by Generic Competition to Key Therapies. |
|
|
Oct 20, 2011 |
634 |
| Research and Markets: Global Parkinson's Disease Drug Pipeline Capsule - 2011 Report Provides Information on Pipeline Molecules by Company and Mechanism of Action across the Different Stages of R&D. |
|
|
Sep 27, 2011 |
411 |
| Researchers Secure Large Grant to Spur Treatments for Parkinson's Disease. |
|
|
Sep 23, 2011 |
1165 |
| Parkinson's medication leaves patients addicted to sex, shopping, Twitter, gambling! |
|
|
Aug 10, 2011 |
289 |
| Chinese herbs could provide new treatment for Parkinson's. |
|
|
Jun 19, 2011 |
211 |
| Animal study shows promising new treatment for Parkinson's disease. |
|
|
Jun 10, 2011 |
199 |
| LILLY/MEDTRONIC DEVELOP NEW PARKINSON DRUG DELIVERY. |
|
|
Jun 1, 2011 |
568 |
| Merck Serono: Data on Parkinson's Disease Investigational Drug Safinamide to Be Presented at AAN 2011 Annual Meeting. |
|
|
Apr 13, 2011 |
624 |
| Teva Announces Presentation of New Data on Multiple Sclerosis and Parkinson's Disease Treatments at 2011 American Academy of Neurology Annual Meeting. |
|
|
Apr 11, 2011 |
1864 |
| Data on IPX066 APEX-PD Phase III Study for the Treatment of Early Parkinson's Disease to be Presented at the American Academy of Neurology Conference. |
|
Conference news |
Apr 1, 2011 |
956 |
| Mayo Clinic Researchers Tie Parkinson's Drugs to Impulse Control Problems. |
|
|
Mar 23, 2011 |
492 |
| Entacapone Was Selected by Nearly Half of Surveyed Neurologists as the Most Effective Levodopa-Adjunct Treatment for Advanced Parkinson's Disease, When Compared to Other Available Therapies. |
|
Survey |
Mar 21, 2011 |
844 |
| 'Novel treatment for advanced Parkinson's disease' found. |
|
|
Mar 18, 2011 |
339 |
| Novel Gene Therapy Agent NLX-P101 Effective in Treating Parkinson's Disease in Phase 2 Trial. |
|
|
Mar 16, 2011 |
2697 |
| Study: 'Meaningful improvements' Using Gene Therapy in Parkinson's Disease. |
|
|
Mar 16, 2011 |
713 |
| IPX066 Demonstrates Efficacy and Safety in ADVANCE-PD Phase III Study in Treatment of Advanced Parkinson's Disease. |
|
Clinical report |
Mar 14, 2011 |
1842 |
| New study could lead to potential drug targets for schizophrenia, Parkinson's. |
|
|
Mar 13, 2011 |
429 |
| Drug that stops progression of Parkinson's disease in mice found. |
|
|
Mar 10, 2011 |
417 |
| Promising new treatment for Parkinson's improves motor control. |
|
|
Feb 3, 2011 |
421 |
| New model paves way for drugs to fight Parkinson's disease. |
|
|
Feb 3, 2011 |
373 |
| Study shows promise in Parkinson's treatment. |
|
|
Jan 1, 2011 |
365 |
| Parkinson's drug effective in treating restless leg syndrome. |
|
|
Dec 7, 2010 |
331 |
| For Parkinson's Disease Treatment, Surveyed Neurologists in France Use Once-Daily Formulations of Requip and Mirapex More Frequently Than Prescribers in Germany, Italy, Spain or the United Kingdom. |
|
|
Nov 30, 2010 |
785 |
| FDA Approves Movement Disorder Drug from CNS Therapeutics: Gablofen[R] (Baclofen Injection) for the Treatment of Severe Spasticity. |
|
|
Nov 23, 2010 |
1367 |
| New hope for Parkinson''s patients over drug effects. |
|
|
Nov 23, 2010 |
271 |
| Impax Pharmaceuticals Announces IPX066 Demonstrates Efficacy and Safety in APEX-PD Phase III Study in Treatment of Early Parkinson's Disease. |
|
Clinical report |
Nov 18, 2010 |
1254 |
| Excess of protein used as anti-cancer drug triggers Parkinson's disease. |
|
|
Oct 3, 2010 |
425 |
| Synosia Presents Data from Clinical Trial of SYN-118 As A New Treatment For Parkinson's Disease. |
|
Clinical report |
Sep 29, 2010 |
690 |
| Increased Uptake of Currently-Available Therapies Will Drive Modest $400 Million Growth in the Parkinson's Disease Drug Market from 2009 to 2019. |
|
|
Sep 9, 2010 |
655 |
| FDA studies Parkinson disease drug for cardiovascular risk. |
|
|
Sep 7, 2010 |
347 |
| Titan Receives SBIR Grant to Investigate Long Term Treatment for Parkinson's Disease. |
|
|
Jul 26, 2010 |
780 |
| Cortex Receives Funding from The Michael J. Fox Foundation to Discover Drug Candidates for Parkinson's Disease. |
|
|
Jul 6, 2010 |
991 |
| Sangamo BioSciences Receives Michael J. Fox Foundation Funding to Develop Novel Drug for the Treatment of Parkinson's Disease. |
|
|
Jul 1, 2010 |
1197 |
| Public Release of Alzheimer's Clinical Trial Data By Pharmaceutical Researchers. |
|
|
Jun 11, 2010 |
1263 |
| Prescription drug for Parkinson's 'can cause porn, gambling addiction'. |
|
|
Jun 5, 2010 |
228 |
| 'Brain pacemaker' - effective treatment for Parkinson's disease. |
|
|
Jun 4, 2010 |
419 |
| DRUGS used to treat Parkinson's [...]. |
|
|
May 17, 2010 |
166 |
| Although Levodopa Remains the Mainstay of Parkinson's Disease Treatment, Physicians Will Increasingly Use Other Agents To Delay the Need for Levodopa. |
|
|
May 12, 2010 |
743 |
| FDA evaluating cancer link in Parkinson's drug. |
|
Brief article |
Apr 6, 2010 |
160 |
| Uptake of Pramipexole ER Will Be Inhibited by Availability of Generic Pramipexole for the Treatment of Parkinson's Disease. |
|
|
Mar 31, 2010 |
739 |
| Promising new approach for Parkinson's disease treatment. |
|
|
Mar 27, 2010 |
335 |
| Rexahn Pharmaceuticals Announces Formation of Parkinson's Disease Scientific Advisory Board. |
|
|
Mar 22, 2010 |
669 |
| Early Tx of dementia helpful in Parkinson's. |
McNamara, Damian |
Clinical report |
Mar 1, 2010 |
677 |
| Dopamine agonists vie with L-dopa for Parkinson's. |
McNamara, Damian |
Clinical report |
Mar 1, 2010 |
489 |
| Heart Medications May Protect against Parkinson. |
|
|
Jan 24, 2010 |
629 |
| Why Parkinson's treatment elicit compulsive behaviours. |
|
|
Jan 14, 2010 |
363 |
| Teva hails milder restrictions on Parkinson's drug. |
|
Brief article |
Dec 22, 2009 |
99 |
| Cholesterol-Lowering Drug May Prevent Progression of Parkinson. |
|
|
Nov 21, 2009 |
455 |
| New discovery can speed up development of Parkinson's drugs. |
|
|
Nov 19, 2009 |
344 |
| SurModics and NuPathe Partner to Develop Novel Long-Acting Parkinson's Treatment. |
|
|
Nov 2, 2009 |
996 |
| Common cholesterol-lowering drug could prevent Parkinson's progression. |
|
|
Nov 1, 2009 |
241 |
| New drug may slow down Parkinson's, Alzheimer's, Huntington's diseases. |
|
|
Oct 28, 2009 |
245 |
| British gene therapy specialist Oxford BioMedica Plc (Oxford, UK) said on Thursday patients had responded well to the second dose of its experimental Parkinson's disease drug, ProSavin, news that sent its shares sharply higher. |
|
|
Oct 19, 2009 |
134 |
| Drug rasagiline may slow Parkinson's progression. |
|
|
Sep 24, 2009 |
398 |
| Swiss biotech Addex Pharmaceuticals' lead drug candidate showed potential to treat a complication of Parkinson's disease in a study with non-human primates. |
|
Brief article |
Sep 21, 2009 |
215 |
| Common drug can function as 'off switch' for Parkinson therapy. |
|
|
Aug 29, 2009 |
632 |
| Soon, a powerful instrument for Parkinson's treatment. |
|
|
Jul 23, 2009 |
373 |
| Novel Drug Discovery Tool Could Identify Promising New Therapies for Parkinson's Disease. |
|
|
Jul 13, 2009 |
101 |
| Parkinson's medications may help treat extreme drug-resistant TB. |
|
|
Jul 3, 2009 |
285 |
| Scientists identify brain protein key to Parkinson's disease, drug addiction. |
|
|
May 6, 2009 |
692 |
| Scientists unveil novel approach to study Parkinson's treatment. |
|
|
Apr 17, 2009 |
406 |
| Parkinson's disease medication may trigger compulsive gambling, hypersexuality. |
|
|
Apr 9, 2009 |
449 |
| Neurologix Commences its Phase 2 Clinical Trial of Novel Gene Transfer Approach for Treatment of Parkinson's Disease. |
|
|
Jan 21, 2009 |
1527 |
| Deep brain stimulation treatment benefits Parkinson's patients. |
|
|
Jan 9, 2009 |
457 |
| Deep brain stimulation treatment benefits Parkinson's patients. |
|
|
Jan 7, 2009 |
457 |
| Sleep kicks linked to Parkinson's; MEDICINE. |
|
|
Dec 26, 2008 |
97 |
| Early Parkinson's progress slowed by rasagiline. |
Sullivan, Michele G. |
Clinical report |
Sep 15, 2008 |
932 |
| Research and Markets: Out Now - CNS Drug Discoveries: Parkinson's Disease Chapter. |
|
|
Sep 1, 2008 |
398 |
| Zelapar reduces dopamine agonist-related events. |
Wendling, Patrice |
Clinical report |
Sep 1, 2008 |
633 |
| Dopaminergics appear to impair impulse control. |
Wendling, Patrice |
Clinical report |
Sep 1, 2008 |
1040 |
| Partial dopamine agonist beneficial in early Parkinson's. |
|
Clinical report |
Sep 1, 2008 |
419 |
| Tricyclic beat SSRI for Parkinson's patients. |
Boschert, Sherry |
Clinical report |
Sep 1, 2008 |
617 |
| Brain stimulation tops medication for Parkinson's. |
Wendling, Patrice |
|
Sep 1, 2008 |
887 |
| Parkinson's Tx may raise risk of impulse control. |
Wendling, Patrice |
|
Aug 1, 2008 |
564 |
| Nonmotor PD symptoms impair quality of life. |
Wachter, Kerri |
|
Mar 15, 2008 |
796 |
| Solvay Pharmaceuticals, Inc. Receives Fast Track Designation From U.S. Food and Drug Administration for Levodopa/Carbidopa Intestinal Gel for Advanced Parkinson's Disease. |
|
|
Feb 18, 2008 |
709 |
| Neurologix Gene Therapy Approach to Parkinson's Disease Granted Fast Track Designation From FDA. |
|
|
Dec 13, 2007 |
1062 |
| Michael J. Fox Foundation and New York Academy of Sciences to Host First Major Parkinson's Drug Development Conference. |
|
Conference news |
Aug 21, 2007 |
570 |
| Adding safinamide to dopamine agonists eases Parkinson's. |
Schonfeld, Amy Rothman |
|
Aug 1, 2007 |
399 |
| Add-on agent boosts control of Parkinson's. |
Schonfeld, Amy Rothman |
|
Jul 1, 2007 |
332 |
| Parkinson's sufferers drug hope. |
|
|
Jun 11, 2007 |
119 |
| Parkinson's sufferers drug hope. |
|
|
Jun 11, 2007 |
112 |
| Drugs breakthrough on Parkinson's treatment. |
|
|
Jun 11, 2007 |
200 |
| Infections, drug changes can bring Parkinson's to the ED. |
Sullivan, Michele G. |
|
Jun 1, 2007 |
852 |
| Parkinson's drug Permax removed from market. |
Ault, Alicia |
Brief article |
May 1, 2007 |
312 |
| Parkinson's drug Permax withdrawn from market. |
Ault, Alicia |
Brief article |
May 1, 2007 |
315 |
| New Blood Test Can Diagnose and Monitor Treatment of Parkinson's Disease. |
|
|
Apr 26, 2007 |
630 |
| Patient sent home with needle in arm; HEALTH: Shocked family hit out over treatment of Parkinson's sufferer. |
|
|
Mar 6, 2007 |
560 |
| FDA GRANTS ORPHAN DRUG DESIGNATION FOR DROXIDOPA. |
|
|
Mar 1, 2007 |
991 |
| WONDER DRUG HAS CHANGED MY LIFE; Parkinson's victim says put it on NHS. |
|
|
Feb 15, 2007 |
376 |
| Two Parkinson's drugs linked with valve damage. |
Bates, Betsy |
|
Feb 1, 2007 |
556 |
| Parkinson's agents linked with 'fen-phen'--like effects: cardiac valvulopathy risk is increased. |
Bates, Betsy |
|
Feb 1, 2007 |
1468 |
| Statin curbs Alzheimer's, Parkinson's. |
Schonfeld, Amy Rothman |
|
Feb 1, 2007 |
388 |
| Proneuron Announces the Receipt of a $430,000 Grant from the Michael J. Fox Foundation to Develop Its PN277 for the Treatment of Parkinson's Disease. |
|
|
Jan 24, 2007 |
452 |
| CHOLESTEROL DRUG PARKINSON'S ALERT; Don't panic plea to users. |
|
|
Jan 15, 2007 |
384 |
| Two drugs widely used to treat Parkinson's disease sharply increase the risk of heart-valve damage, researchers said. |
|
Brief article |
Jan 8, 2007 |
145 |
| Ecstasy and Parkinson's disease. |
|
Brief article |
Jan 1, 2007 |
143 |
| Simvastatin may cut Alzheimer's, Parkinson's risk. |
Schonfeld, Amy Rothman |
Brief article |
Dec 1, 2006 |
257 |
| MAO inhibitor is approved for Parkinson's. |
Mechcatie, Elizabeth |
|
Aug 1, 2006 |
847 |
| Parkinson's disease. |
Golden, William E.; Hopkins, Robert H. |
Disease/Disorder overview |
Aug 1, 2006 |
778 |
| Keep an open mind about CAM for Parkinson's. |
Wachter, Kerri |
|
Jul 1, 2006 |
881 |
| Azilect. |
Mechcatie, Elizabeth |
Drug overview |
Jun 15, 2006 |
335 |
| Four new Parkinson's disease guidelines hailed: review finds insufficient evidence to show that alternative therapies benefit Parkinson's patients. |
Schonfeld, Amy Rothman |
Statistical data |
Jun 1, 2006 |
824 |
| Teva Announces FDA Grants Approval of AZILECT(R) (Rasagiline) for Parkinson's Disease. |
|
|
May 17, 2006 |
1264 |
| Selegiline serves as effective adjunct for PD symptoms. |
Wachter, Kerri |
Disease/Disorder overview |
May 1, 2006 |
449 |
| Selegiline safe, effective as adjunct for Parkinson's. |
Wachter, Kerri |
|
May 1, 2006 |
573 |
| Treating parkinsonism in HIV-positive patients can spur infection, psychosis. |
Wachter, Kerri |
Statistical data |
Apr 1, 2006 |
339 |
| Reward-based behavior common in Parkinson's. |
Bates, Betsy |
|
Mar 1, 2006 |
593 |
| Rasagiline controls early Parkinson's symptoms. |
Sullivan, Michele G. |
|
Jun 15, 2005 |
646 |
| Neuroleptic malignant syndrome in a patient with Parkinson's disease: a case study. |
Ward, Constance |
|
Jun 1, 2005 |
1881 |
| Rivastigmine may delay dementia in Parkinson's. |
Evans, Jeff |
|
Apr 1, 2005 |
643 |
| Rivastigmine may delay dementia in Parkinson's. |
Evans, Jeff |
|
Mar 1, 2005 |
560 |
| New drugs curb 'off' episodes in advanced Parkinson's. |
Jancin, Bruce |
|
Jan 1, 2005 |
514 |
| Rivastigmine benefits dementia in Parkinson's. |
Zoler, Mitchel L. |
|
Nov 1, 2004 |
587 |
| Curbing 'off' episodes in advanced Parkinson's. |
Jancin, Bruce |
|
Sep 15, 2004 |
608 |
| Rivastigmine fights Parkinson's disease dementia. |
Zoler, Mitchel L. |
|
Sep 1, 2004 |
661 |
| Federal panel proposes human clinical trials xenotransplants trials begin soon in Australia. |
|
Brief Article |
Feb 16, 2004 |
273 |
| Sertraline okay for depression in Parkinson's disease: open-label trial. |
Finn, Robert |
Brief Article |
Sep 1, 2003 |
208 |
| Drug update: Parkinson's disease. |
Mahoney, Diana |
|
Sep 1, 2003 |
1250 |
| SSRI for depression in Parkinson's. (Sertraline Might Help). |
Finn, Robert |
Brief Article |
Jul 1, 2003 |
190 |
| Early levodopa appears to slow course of Parkinson's: no evidence of accelerated progression. (9-Month Randomized Trial). |
Finn, Robert |
|
May 1, 2003 |
493 |
| Early levodopa seems to slow Parkinson's. (9-Month Randomized Trial). |
Finn, Robert |
|
May 1, 2003 |
429 |
| Parkinson's drugs could put patients at risk. |
|
|
Mar 22, 2003 |
584 |
| Medications to be avoided by Parkinson patients. |
|
Illustration |
Mar 22, 2003 |
119 |
| Supplement may offer relief from Parkinson's disease. |
|
Brief Article |
Mar 22, 2003 |
138 |
| Rivastigmine appears effective for Parkinson's hallucinations. (Motor Control Unchanged). |
Jancin, Bruce |
Brief Article |
Jun 1, 2002 |
195 |
| Rivastigmine appears to ease Parkinsonian hallucinations. (No Motor Control Decreases in Study). |
Jancin, Bruce |
Brief Article |
Jun 1, 2002 |
277 |
| Eight key points for treating Parkinson's disease. (Clinical Rounds: Primary care should take charge). |
Jancin, Bruce |
Brief Article |
Apr 1, 2002 |
544 |
| Modafinil Limits Daytime Sleepiness in Parkinson's. (Study of 21 Patients). |
Yasgur, Batya Swift |
|
Nov 1, 2001 |
223 |
| Parkinson's Guidelines Advise Dopamine Agonist. |
McNAMARA, DAMIAN |
|
Jul 15, 2001 |
724 |
| DEVASTATING SIDE EFFECTS ACCOMPANY FETAL TISSUE TRANSPLANTS. |
Andrusko, Dave |
Brief Article |
Mar 1, 2001 |
614 |
| Apomorphine in the Treatment of Parkinson's Disease. |
Odin, Per; Hagell, Peter |
Statistical Data Included |
Feb 1, 2001 |
12213 |
| Caffeine may ward off Parkinson's. |
J.T. |
Brief Article |
Nov 25, 2000 |
319 |
| An alternate approach to Parkinson's. |
N.S. |
Brief Article |
Jun 10, 2000 |
264 |
| Drug Therapy to Manage Parkinson's Disease |
|
|
Oct 9, 1996 |
1505 |
|
